Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „deferiprone“
Suchtreffer
Begriffe & Kennungen
Deferiprone Lipomed · 4.8 · Neurological disorders (such as cerebellar symptoms, diplopia, lateral nystagmus, psychomotor slowdown, hand m
Eintrag öffnenDeferiprone Lipomed · 4.8 · Paediatric population
Eintrag öffnenDeferiprone Lipomed · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenDeferiprone Lipomed · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenDeferiprone Lipomed · 4.8 · Some patients experienced progression of fibrosis associated with an increase in iron overload or hepatitis C.
Eintrag öffnenDeferiprone Lipomed · 4.8 · Summary of the safety profile
Eintrag öffnenDeferiprone Lipomed · 4.8 · System organ class Very common Common Frequency not known Blood and lymphatic system Agranulocytosis disorders
Eintrag öffnenDeferiprone Lipomed · 4.8 · The adverse reactions are listed below by system organ class (SOC) and by frequency, with the following freque
Eintrag öffnenDeferiprone Lipomed · 4.8 · The incidences of adverse reactions experienced by 18 children and 97 adults treated with combination therapy
Eintrag öffnenDeferiprone Lipomed · 4.8 · The most common adverse reactions reported during therapy with deferiprone in clinical trials were nausea, vom
Eintrag öffnenDeferiprone Lipomed · 4.8 · The most serious adverse reaction reported in clinical trials with deferiprone is agranulocytosis (neutrophils
Eintrag öffnenDeferiprone Lipomed · 4.8 · The observed incidence of the less severe form of neutropenia (neutrophils <1.5 x 109/l) is 4.9% (2.5 cases pe
Eintrag öffnenDeferiprone Lipomed · 4.8 · The safety profile of combination therapy (deferiprone and deferoxamine) observed in clinical trials, post-mar
Eintrag öffnenDeferiprone Lipomed · 4.8 · Within each frequency grouping, adverse reactions are presented in the order of decreasing seriousness.
Eintrag öffnenFerriprox · 4.5 · Due to the unknown mechanism of deferiprone-induced neutropenia, patients must not take medicinal products kno
Eintrag öffnenFerriprox · 4.5 · Due to the unknown mechanism of deferiprone-induced neutropenia, patients must not take medicinal products kno
Eintrag öffnenFerriprox · 4.5 · Since deferiprone binds to metallic cations, the potential exists for interactions between deferiprone and tri
Eintrag öffnenFerriprox · 4.5 · Since deferiprone binds to metallic cations, the potential exists for interactions between deferiprone and tri
Eintrag öffnenFerriprox · 4.5 · The safety of concurrent use of deferiprone and vitamin C has not been formally studied. Based on the reported
Eintrag öffnenFerriprox · 4.5 · The safety of concurrent use of deferiprone and vitamin C has not been formally studied. Based on the reported
Eintrag öffnen